In contrast, NPs can be engineered for targeted delivery to ischemic regions of the brain, effectively modulating the PI3K/AKT/CREB signaling pathway, which is vital for neuronal survival, synaptic repair, and resistance to apoptosis following a stroke (Lv et al., 2022a). The gene discussed is CREB1; the disease is stroke disorder.